Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study
ConclusionsTreatment with aCD20 or SP1-M therapies appears to be associated with a lower humoral response to vaccines against SARS-CoV-2. Vaccination prior to initiation of these DMTs should be recommended whenever possible.
Source: Neurology and Therapy - Category: Neurology Source Type: research
More News: Brain | Coronavirus | Covid Vaccine | COVID-19 | Gilenya | Multiple Sclerosis | Neurology | Rituxan | SARS | Spain Health | Study | Vaccines